Citadel Advisors’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
102,783
+59,815
| +139% | +$456K | ﹤0.01% | 3565 |
|
|
2025
Q1 | $140K | Sell |
42,968
-701,564
| -94% | -$2.29M | ﹤0.01% | 5025 |
|
|
2024
Q4 | $3.35M | Sell |
744,532
-471,339
| -39% | -$2.12M | ﹤0.01% | 2128 |
|
|
2024
Q3 | $3.37M | Buy |
1,215,871
+20,876
| +2% | +$57.8K | ﹤0.01% | 2075 |
|
|
2024
Q2 | $4.09M | Buy |
1,194,995
+1,164,729
| +3,848% | +$3.98M | ﹤0.01% | 1834 |
|
|
2024
Q1 | $164K | Buy |
+30,266
| New | +$164K | ﹤0.01% | 4876 |
|
|
2023
Q4 | – | Sell |
-311,634
| Closed | -$2.74M | – | 6581 |
|
|
2023
Q3 | $2.74M | Buy |
+311,634
| New | +$2.74M | ﹤0.01% | 2106 |
|